Skip to main content
BiotaSiftPartner sign in
A PoeticPremium BioStudio product · One Health discovery

Discover carefully.
Develop responsibly.

BiotaSift prioritises environmental antimicrobial peptide candidates with a practical route to testing, an auditable evidence trail and a thoughtful view of potential non-target impact.

Explore the interactive demo How partner access works

Computational prioritisation, not experimental validation or a demonstrated ecological-safety claim.

ATLAS / PUBLIC PROGRESS

The discovery landscape, in context.

We track the scale and breadth of the discovery process, not just the final shortlist. Public figures appear here only after a source review.

Peptides entering screening
Pending verification

Distinct input peptides screened; not predicted hits.

Environmental contexts covered
Pending verification

Reviewed biome or habitat categories represented in the source inventory.

Evidence and filtering stages
Pending verification

Distinct, documented screening layers; not model confidence levels.

Release counts are not a measure of peptide efficacy or ecological safety. Progress numbers are updated manually from approved, traceable summaries. No public numerical totals have been approved for this panel yet.

01 / THE PROCESS

From environmental data
to considered decisions.

Scientific evidence stays versioned and separate from the partner-facing platform. Every release is traceable; proprietary candidate information remains controlled.

01

Discover

Environmental sequence data enters an auditable scientific workflow.

02

Prioritise

Candidate evidence is assessed across novelty, manufacturability and safety proxies.

03

EcoSparing

Contextual non-target impact and One Health considerations inform prioritisation.

04

Validate

Candidates move toward laboratory testing through controlled partner access.

02 / ECOSPARING

Look beyond
target activity.

EcoSparing adds context-aware consideration of possible non-target microbiome effects to candidate prioritisation. Current results are prediction- and proxy-based and carry substantial uncertainty.

We do not claim proven microbiome preservation, host safety or ecological safety without appropriate laboratory evidence.

03 / SCIENCE & TRUST

Evidence that knows
its own limits.

The frozen scientific backend integrates evidence layers across novelty, development feasibility, safety proxies, mechanism, EcoSparing and structural triage.

REPRODUCIBILITY

Versioned release

Scientifically frozen Phase 1L evidence with explicit provenance and validation boundaries.

RESPONSIBLE ACCESS

Selective disclosure

Partner previews are strictly scoped to authorised organisations, projects and entitlements.

LABORATORY PATH

Validation first

Discovery outputs guide experimental design; activity, safety and utility are not presumed.

COLLABORATION

Explore the possibilities,
with the right access.

Interested in research collaborations, agriculture, aquaculture or licensing discussions? Contact the BioStudio directly. Existing approved partners can use the secure portal.

Discuss a collaboration ↗ Existing partner portal ↗